Xeris Biopharma Holdings, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$5,940,409
18 notices · 790,885 sh
Oct 2025 to Oct 2026
Reported ·
$2,912,659
19 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
15 of 19 reported sales carry the 10b5-1 box. Together they are 0.23% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-10-01BETH HECHT, See Remarks$159,327
2026-09-28KEVIN MCCULLOCH, See Remarks$637,000
2026-08-12STEVEN PIEPER, See Remarks$167,800
2026-07-07STEVEN PIEPER, See Remarks$231,012
2026-07-06STEVEN PIEPER, See Remarks$144,072
2026-07-01BETH HECHT, See Remarks$395,984
2026-07-01KEVIN MCCULLOCH, See Remarks$950,400
2026-06-04DAWN HALKUFF, Director$117,800
Form 4, 2026-06-05: sold 20,000 at $6.09 Form 4 ↗
2026-06-04JOHN H JOHNSON, Director$88,350
Form 4, 2026-06-05: sold 15,000 at $6.09 Form 4 ↗
2026-06-04Barbara-Jean Bormann-Kennedy, Director$94,240
Form 4, 2026-06-05: sold 16,000 at $6.09 Form 4 ↗
2026-06-03MARLA PERSKY, Director$93,000
Form 4, 2026-06-05: sold 15,500 at $5.90 Form 4 ↗
2026-03-30JAMES BRADY, Director$58,504
Form 4, 2026-04-01: sold 10,834 at $5.54 Form 4 ↗
2026-03-02BETH HECHT, See Remarks$408,008
Form 4, 2026-03-04: sold 16,667 at $6.24 Form 4 ↗
2026-01-08KEVIN MCCULLOCH, See Remarks$432,600
Form 4, 2026-01-09: sold 15,000 at $8.00 Form 4 ↗
2025-12-19JOHN H JOHNSON, Director$977,034
Form 4, 2025-12-19: sold 135,400 at $7.22 Form 4 ↗
2025-12-12BARBARA-JEAN A BORMANN-KENNEDY, Director$105,150
Form 4, 2025-12-15: sold 15,000 at $7.09 Form 4 ↗
2025-11-13JOHN SHANNON, See Remarks$365,451
Form 4, 2025-11-17: sold 23,242 at $7.46 Form 4 ↗